Evotec SE (EVO) Non Operating Income (2009 - 2025)
Evotec SE (EVO) posted Non Operating Income of $1802.7 for Q3 2025, up 108.05% sequentially from -$22382.8 in Q3 2024, and up 108.05% YoY from $866.45 in Q3 2024.
Evotec SE (EVO) Non Operating Income (2009 - 2025) Analysis & Trends
Evotec SE has reported Non Operating Income for 9 years, with the latest figure at $1802.7 in Q3 2025.
- Quarterly Non Operating Income rose 108.05% year-over-year to $1802.7 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$178.5 million (changed 0.02% YoY) and the FY2022 annual result came in at -$178.3 million, down 179.55% from the prior year.
- Non Operating Income climbed to $1802.7 in Q3 2025 per EVO's latest filing, from -$22382.8 in the prior quarter.
- Over five years, Non Operating Income peaked at $223.9 million in Q4 2021 and troughed at -$178.5 million in Q4 2022.
- A 5-year average of $4.2 million and a median of $19299.6 in 2023 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2021 and 2022: Non Operating Income surged 41923.99% in 2021, then slumped 235.08% in 2022.
- Over 5 years, Non Operating Income stood at $223.9 million in 2021, then slumped by 179.7% to -$178.5 million in 2022, then soared by 100.01% to $19299.6 in 2023, then sank by 215.98% to -$22382.8 in 2024, then jumped by 108.05% to $1802.7 in 2025.
- According to Business Quant data, Non Operating Income over the past three periods registered $1802.7, -$22382.8, and $19299.6 for Q3 2025, Q3 2024, and Q3 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Evotec SE | 692.56 Mn | 692.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,802.68 |
| Sep 30, 2024 | -22,382.81 |
| Sep 30, 2023 | 19,299.62 |
| Dec 31, 2022 | -178.47 Mn |
| Sep 30, 2022 | 30,081.86 |
| Jun 30, 2022 | -21,945.09 |
| Mar 31, 2022 | -77,661.28 |
| Dec 31, 2021 | 223.94 Mn |
| Sep 30, 2021 | 144,643.13 |
| Jun 30, 2021 | 70,387.26 |
| Mar 31, 2021 | 57,491.63 |
| Dec 31, 2020 | 532,882.03 |
| Sep 30, 2020 | -10,333.98 |
| Dec 31, 2019 | -6.68 Mn |
| Sep 30, 2010 | 242.76 |
| Jun 30, 2010 | 67.57 |
| Mar 31, 2010 | 160.63 |
| Dec 31, 2009 | -3.72 Mn |
| Jun 30, 2009 | 369.01 |
| Mar 31, 2009 | -2.07 |